TrialDiabetes, obesity & metabolism2020

Pharmacokinetic and dose-finding studies on efpeglenatide in patients with type 2 diabetes.

Kun-Ho Yoon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.